Перспективы переработки рыбы на предприятии филиал «Браславрыба» ОАО «Глубокский МКК»

В статье представлен анализ работы рыбоперерабатывающего предприятия «Браславрыба» филиала ОАО «Глубокский МКК». Дана характеристика ассортимента выпускаемой продукции, приведен сравнительный анализ цен товарной продукции различных производителей. Предложены возможные варианты повышения конкурентоспособности предприятия на внутреннем и внешнем рынках за счет снижения себестоимости выпускаемой продукции. = The paper presents an analysis of the fish processing plant Branch «Braslavryba» of «Glubokskiy ICC». The characteristic of the product range, the comparative analysis of prices for canned different manufacturers. The possible options to improve the company's competitiveness in the domestic and for-eign markets by reducing the cost of production. Keywords: fish processing, production, price analysis

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Prospects of Fish Processing Enterprise Branch «Braslavryba» JSC «Glubokskiy MCC»

В статье представлен анализ работы рыбоперерабатывающего предприятия «Браславрыба» филиала ОАО «Глубокский МКК». Дана характеристика ассортимента выпускаемой продукции, приведен сравнительный анализ цен товарной продукции различных производителей. Предложены возможные варианты повышения конкурентоспособности предприятия на внутреннем и внешнем рынках за счет снижения себестоимости выпускаемой продукции.The paper presents an analysis of the fish processing plant Branch «Braslavryba» of «Glubokskiy ICC». The characteristic of the product range, the comparative analysis of prices for canned different manufacturers. The possible options to improve the company's competitiveness in the domestic and foreign markets by reducing the cost of production